Integral Derivatives’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-18,977
Closed -$1.23M 1106
2015
Q3
$1.23M Buy
18,977
+13,800
+267% +$1.02M 0.03% 442
2015
Q2
$424K Buy
+5,177
New +$399K 0.01% 772
2014
Q4
Sell
-16,877
Closed -$1.33M 1414
2014
Q3
$1.36M Buy
16,877
+5,100
+43% +$426K 0.02% 603
2014
Q2
$1.03M Sell
11,777
-6,400
-35% -$556K 0.02% 676
2014
Q1
$1.57M Sell
18,177
-1,700
-9% -$139K 0.03% 503
2013
Q4
$1.6M Buy
+19,877
New +$1.54M 0.02% 597

Other funds holding EMN

Integral Derivatives's EMN Position: Q4 2015 in Review

Integral Derivatives sold out of Eastman Chemical (EMN) in Q4 2015, closing a stake of 18,977 shares — an estimated $1.23M sold.

Integral Derivatives first reported a position in EMN in Q4 2013 and held it in 6 quarters. The position peaked at $1.6M in Q4 2013. 557 funds tracked by Wall St. Rank hold EMN as of Q4 2015.

  • Integral Derivatives reported no remaining Eastman Chemical position as of Q4 2015 after selling out during the quarter.
  • Integral Derivatives sold 18,977 Eastman Chemical shares in Q4 2015, an estimated $1.23M.
  • Integral Derivatives first reported a position in Eastman Chemical in Q4 2013 and held it in 6 quarters.
  • Integral Derivatives's Eastman Chemical position peaked at $1.6M in Q4 2013.
  • 557 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2015.

Based on Integral Derivatives's 13F filing for Q4 2015, filed 22 Jan 2016.